Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70(10):1989–2003. 10.1136. PubMed PMID: 34266966; PubMed Central PMCID: PMCQ1. /gutjnl-2020-322362.

Article  PubMed  Google Scholar 

Horst AK, Kumashie KG, Neumann K, Diehl L, Tiegs G. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease. Cell Mol Immunol. 2021;18(1). https://doi.org/10.1038/s41423-020-00568-6. PubMed PMID: 33110250; PubMed Central PMCID: PMCQ1.

Shah RA, Kowdley KV. Current and potential treatments for primary biliary cholangitis. Lancet Gastroenterol Hepatol. 2020;5(3):306–15. https://doi.org/10.1016/S2468-1253. (19)30343-7. PubMed PMID: 31806572; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Floreani A, Restrepo-Jiménez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, et al. Etiopathogenesis of autoimmune hepatitis. J Autoimmun. 2018;95:133–43. https://doi.org/10.1016/j.jaut.2018.10.020. PubMed PMID: 30385083; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Lamba M, Ngu JH, Stedman CAM. Trends in incidence of Autoimmune Liver diseases and increasing incidence of Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2021;19(3). https://doi.org/10.1016/j.cgh.2020.05.061. PubMed PMID: 32526342; PubMed Central PMCID: PMCQ1.

Yokoda RT, Carey EJ. Primary biliary cholangitis and primary sclerosing Cholangitis. Am J Gastroenterol. 2019;114(10):1593–605. https://doi.org/10.14309/ajg.0000000000000268. PubMed PMID: 31169523; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Lleo A, Wang G-Q, Gershwin ME, Hirschfield GM. Primary biliary cholangitis. Lancet. 2020;396(10266):1915–26. https://doi.org/10.1016/S0140-6736. (20)31607-X. PubMed PMID: 33308474; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Barberio B, Massimi D, Cazzagon N, Zingone F, Ford AC, Savarino EV. Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and Meta-analysis. Gastroenterology. 2021;161(6):1865–77. https://doi.org/10.1053/j.gastro.2021.08.032. PubMed PMID: 34425093; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Vesterhus M, Karlsen TH. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. J Gastroenterol. 2020;55(6):588–614. https://doi.org/10.1007/s00535-020-01681-z. PubMed PMID: 32222826; PubMed Central PMCID: PMCQ1.

Article  PubMed  PubMed Central  Google Scholar 

Webb GJ, Ryan RP, Marshall TP, Hirschfield GM. The epidemiology of UK Autoimmune Liver Disease varies with Geographic Latitude. Clin Gastroenterol Hepatol. 2021;19(12):2587–96. https://doi.org/10.1016/j.cgh.2021.01.029. PubMed PMID: 33493696; PubMed Central PMCID: PMCQ1.

Article  PubMed  PubMed Central  Google Scholar 

Trivella J, John BV, Levy C. Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatol Commun. 2023;7(6). 10.1097/. HC9.0000000000000179. PubMed PMID: 37267215; PubMed Central PMCID: PMCQ2.

Liu S-P, Bian Z-H, Zhao Z-B, Wang J, Zhang W, Leung PSC, et al. Animal models of Autoimmune Liver diseases: a Comprehensive Review. Clin Rev Allergy Immunol. 2020;58(2):252–71. https://doi.org/10.1007/s12016-020-08778-6. PubMed PMID: 32076943; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Sy AM, Ferreira RD, John BV. Hepatocellular Carcinoma in primary biliary cholangitis. Clin Liver Dis. 2022;26(4):691–704. https://doi.org/10.1016/j.cld.2022.06. .011. PubMed PMID: 36270724; PubMed Central PMCID: PMCQ2.

Article  PubMed  Google Scholar 

Chang C, Tanaka A, Bowlus C, Gershwin ME. The use of biologics in the treatment of autoimmune liver disease. Expert Opin Investig Drugs. 2020;29(4):385–98. PubMed PMID: 32102572; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018;67(9):1568–94. https://doi.org/10.1136/gutjnl-2017-315259. PubMed PMID: 29593060; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2021 practice guidance update from the American Association for the study of Liver diseases. Hepatology (Baltimore MD). 2022;75(4):1012–3. https://doi.org/10.1002/hep.32117. PubMed PMID: 34431119; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Carey EJ. Progress in primary biliary cholangitis. N Engl J Med. 2018;378(23):2234–5. 10.1056/. NEJMe1804945. PubMed PMID: 29874531; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Huang L-X, Wang Z-L, Jin R, Chen H-S, Feng B. Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms. Expert Rev Gastroenterol Hepatol. 2022;16(11–12):1065–78. PubMed PMID: 36469627; PubMed Central PMCID: PMCQ2.

Article  CAS  PubMed  Google Scholar 

Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of Inflammatory Bowel Disease: current concepts, treatment, and implications for Disease Management. Gastroenterology. 2021;161(4):1118–32. https://doi.org/10.1053/j.gastro.2021.07.042. PubMed PMID: 34358489; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Floreani A, De Martin S, Secchi MF, Cazzagon N. Extrahepatic autoimmunity in autoimmune liver disease. Eur J Intern Med. 2019;59:1–7. https://doi.org/10.1016/j.ejim.2018.10.014. PubMed PMID: 30360943; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Floreani A, Franceschet I, Cazzagon N. Primary biliary cirrhosis: overlaps with other autoimmune disorders. Semin Liver Dis. 2014;34(3):352 – 60. doi: 10.1055/s-0034-1383734. PubMed PMID: 25057958; PubMed Central PMCID: PMCQ2.

Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L. Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol. 2015;27(10):1175–9. 10.1097/MEG.0000000000000424. PubMed PMID: 26148248; PubMed Central PMCID: PMCQ4.

Article  CAS  PubMed  Google Scholar 

Parés A, Guañabens N. Bone fractures in primary biliary cholangitis. J Intern Med. 2023;294(2):159–60. https://doi.org/10.1111/joim.13644. PubMed PMID: 37165698; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Schönau J, Wester A, Schattenberg JM, Hagström H. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: a population-based cohort study. J Intern Med. 2023;294(2):164–77. https://doi.org/10.1111/joim.13624. PubMed PMID: 36823685; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A. Osteoporosis in primary biliary cholangitis. World J Gastroenterol. 2018;24(31):3513–20. https://doi.org/10.3748/wjg.v24.i31.3513. PubMed PMID: 30131657; PubMed Central PMCID: PMCQ2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seki A, Ikeda F, Miyatake H, Takaguchi K, Hayashi S, Osawa T, et al. Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis. J Gastroenterol Hepatol. 2017;32(9):1611–6. https://doi.org/10.1111/jgh.13746. PubMed PMID: 28114749; PubMed Central PMCID: PMCQ2.

Article  CAS  PubMed  Google Scholar 

Parés A, Guañabens N. Primary biliary cholangitis and bone disease. Best Pract Res Clin Gastroenterol. 2018;34–35:63–70. https://doi.org/10.1016/j.bpg.2018.06. .005. PubMed PMID: 30343712; PubMed Central PMCID: PMCQ3.

Article  PubMed  Google Scholar 

Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013;37(5):535–45. https://doi.org/10.1016/j.clinre.2013.05.016. PubMed PMID: 23845396; PubMed Central PMCID: PMCQ3.

Article  CAS  PubMed  Google Scholar 

Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology (Baltimore MD). 2002;35(1):126–31. PubMed PMID: 11786968; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  Google Scholar 

Wang Z, Peng C, Wang P, Sui J, Wang Y, Sun G, et al. Serum vitamin D level is related to disease progression in primary biliary cholangitis. Scand J Gastroenterol. 2020;55(11):1333–40. PubMed PMID: 33021858; PubMed Central PMCID: PMCQ4.

Article  CAS  PubMed  Google Scholar 

Xu H, Wu Z, Feng F, Li Y, Zhang S. Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: a mendelian randomization study. Front Immunol. 2022;13:1055953. https://doi.org/10.3389/fimmu.2022.1055953. PubMed PMID: 36605198; PubMed Central PMCID: PMCQ1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebadi M, Ip S, Lytvyak E, Asghari S, Rider E, Mason A, et al. Vitamin D is Associated with Clinical outcomes in patients with primary biliary cholangitis. Nutrients. 2022;14(4). https://doi.org/10.3390/nu14040878. PubMed PMID: 35215528; PubMed Central PMCID: PMCQ1.

Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, et al. Decreased expression of vitamin D receptor affects an Immune response in primary biliary cholangitis via the VDR-miRNA155-SOCS1 pathway. Int J Mol Sci. 2017;18(2). https://doi.org/10.3390/ijms18020289. PubMed PMID: 28146070; PubMed Central PMCID: PMCQ1.

Kempinska-Podhorodecka A, Adamowicz M, Chmielarz M, Janik MK, Milkiewicz P, Milkiewicz M. Vitamin-D receptor-gene polymorphisms affect quality of life in patients with Autoimmune Liver diseases. Nutrients. 2020;12(8). https://doi.org/10.3390/nu12082244. PubMed PMID: 32727130; PubMed Central PMCID: PMCQ1.

Gong L, Wei F, Gonzalez FJ, Li G. Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. Hepatology (Baltimore MD). 2023;78(5):1625–53. https://doi.org/10.1097/HEP.0000000000000182. PubMed PMID: 36626642; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Kempińska-Podhorodecka A, Abramczyk J, Cielica E, Huła B, Maciejowska H, Banales J, et al. Effect of low testosterone levels on the expression of Proliferator-activated receptor alpha in female patients with primary biliary cholangitis. Cells. 2023;12(18). https://doi.org/10.3390/cells12182273. PubMed PMID: 37759496; PubMed Central PMCID: PMCQ2.

Wu J, Fan X, Song Y. The causal effect of bioavailable testosterone on primary biliary cholangitis in female patients: a bidirectional mendelian randomization analysis. Dig Liver Dis. 2023;55(8):1091–7. https://doi.org/10.1016/j.dld.2023.02.020. PubMed PMID: 36922303; PubMed Central PMCID: PMCQ2.

Article  CAS  PubMed  Google Scholar 

Schwinge D, Schramm C. Sex-related factors in autoimmune liver diseases. Semin Immunopathol. 2019;41(2):165–75. https://doi.org/10.1007/s00281-018-0715-8. PubMed PMID: 30276446; PubMed Central PMCID: PMCQ1.

Article  PubMed  Google Scholar 

Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol. 2016;27(11):3253–65. PubMed PMID: 27486138; PubMed Central PMCID: PMCQ1.

Article  PubMed  PubMed Central  Google Scholar 

Boef AGC, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2):496–511. https://doi.org/10.1093/ije/dyv071. PubMed PMID: 25953784; PubMed Central PMCID: PMCQ1.